רקוויפ מודוטאב 2 מג Izraēla - ivrits - Ministry of Health

רקוויפ מודוטאב 2 מג

glaxo smith kline (israel) ltd - ropinirole as hydrochloride - טבליות מצופות פילם - שחרור ממושך - ropinirole as hydrochloride 2 mg - ropinirole - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

רקוויפ מודוטאב 8 מג Izraēla - ivrits - Ministry of Health

רקוויפ מודוטאב 8 מג

glaxo smith kline (israel) ltd - ropinirole as hydrochloride - טבליות מצופות פילם - שחרור ממושך - ropinirole as hydrochloride 8 mg - ropinirole - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

רקוויפ מודוטאב 4 מג Izraēla - ivrits - Ministry of Health

רקוויפ מודוטאב 4 מג

glaxo smith kline (israel) ltd - ropinirole as hydrochloride - טבליות מצופות פילם - שחרור ממושך - ropinirole as hydrochloride 4 mg - ropinirole - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

בוטרנס 5 Izraēla - ivrits - Ministry of Health

בוטרנס 5

rafa laboratories ltd - buprenorphine - מדבקות במבנה מטריצה - buprenorphine 5 mg - oripavine derivatives - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.

בוטרנס 10 Izraēla - ivrits - Ministry of Health

בוטרנס 10

rafa laboratories ltd - buprenorphine - מדבקות במבנה מטריצה - buprenorphine 10 mg - oripavine derivatives - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.

בוטרנס 20 Izraēla - ivrits - Ministry of Health

בוטרנס 20

rafa laboratories ltd - buprenorphine - מדבקות במבנה מטריצה - buprenorphine 20 mg - oripavine derivatives - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.

בוטרנס 15 Izraēla - ivrits - Ministry of Health

בוטרנס 15

rafa laboratories ltd - buprenorphine - מדבקות במבנה מטריצה - buprenorphine 15 mg - buprenorphine

כלורטטרציקלין תרסיס וטרינרי Izraēla - ivrits - Ministry of Health

כלורטטרציקלין תרסיס וטרינרי

abic veterinary products ltd - chlortetracycline as hydrochloride - ספריי - chlortetracycline as hydrochloride 3.210 g/container